Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Korro Bio (KRRO) Equity Ratio (2019 - 2025)

Korro Bio's Equity Ratio history spans 7 years, with the latest figure at 0.45 for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio fell 36.09% year-over-year to 0.45, compared with a TTM value of 0.45 through Dec 2025, down 36.09%, and an annual FY2025 reading of 0.45, down 36.09% over the prior year.
  • Equity Ratio for Q4 2025 was 0.45 at Korro Bio, down from 0.61 in the prior quarter.
  • The five-year high for Equity Ratio was 0.79 in Q2 2024, with the low at 3.31 in Q3 2023.
  • Average Equity Ratio over 5 years is 0.13, with a median of 0.66 recorded in 2022.
  • Year-over-year, Equity Ratio plummeted 648.64% in 2023 and then surged 165.63% in 2024.
  • Tracing KRRO's Equity Ratio over 5 years: stood at 0.23 in 2021, then crashed by 489.76% to 1.34 in 2022, then soared by 157.08% to 0.77 in 2023, then decreased by 7.5% to 0.71 in 2024, then crashed by 36.09% to 0.45 in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Equity Ratio are 0.45 (Q4 2025), 0.61 (Q3 2025), and 0.64 (Q2 2025).